Accepting PhD Students

PhD projects

Anti-cancer compounds Molecules against neurodegenerative diseases Anti-microbial chelators Therapeutic Metal chelators

Willing to speak to media

  • Source: Scopus
If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Metal chelators as therapeutic compounds, in particular in cancer, neurodegenerative diseases and as biostatic agents against microorganisms.

We focus on the design of powerful Fe(III) chelators of the hydroxypyridinone family that have been demonstrated by us and others to have activity as:

anticancer drugs, interfering with the biochemical processes involving metals (metalloenzymes, oxidative stress)

drugs against neurodegenerative diseases, preventing oxidative damage to neurons

biostatic agents, reducing the rate of growth of microorganisms.


I am an organic chemist who is designing novel powerful metal chelators, with a focus on Fe(III) that can have therapeutic applications, in particular against cancer, neurodegenerative diseases (Parkinson's Disease, Alzheimer's Disease) and as biostatic agents against micro-organisms. My molecules are based on rationale design, trying to optimise metal chelator and other functions such as cell penetration, multiple mode of action, targeting.

Education/Academic qualification

Teaching & Learning, PCAPL

11 Oct 200710 Oct 2008

Award Date: 10 Oct 2008

Chemistry, PhD

1 Sep 199330 Oct 1996

Award Date: 30 Oct 1996


Dive into the research topics where David Tetard is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or